Helmy Eltoukhy - 31 Dec 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy
Issuer symbol
GH
Transactions as of
31 Dec 2024
Transactions value $
-$1,500,555
Form type
4
Filing time
03 Jan 2025, 17:52:44 UTC
Previous filing
01 Oct 2024
Next filing
13 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +11.5K +0.5% $0.00 2.32M 31 Dec 2024 Direct
transaction GH Common Stock Tax liability -$177K -5.81K -0.25% $30.55 2.31M 31 Dec 2024 Direct F1
transaction GH Common Stock Options Exercise $0 +94.6K +4.09% $0.00 2.4M 01 Jan 2025 Direct
transaction GH Common Stock Tax liability -$1.32M -43.3K -1.8% $30.55 2.36M 01 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -11.5K -100% $0.00 0 31 Dec 2024 Common Stock 11.5K $0.00 Direct F2, F3
transaction GH Restricted Stock Units Options Exercise $0 -94.6K -33% $0.00 192K 01 Jan 2025 Common Stock 94.6K $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This restricted stock unit award was granted on March 18, 2024 and vests in four equal installments on the last day of each calendar quarter, March 31st, June 30th, September 30th, and December 31st, 2024.
F3 Not applicable for Restricted Stock Units.
F4 This restricted stock unit award was granted on March 18, 2024 and vests with respect to 1/3 of the shares on January 1, 2025, and then quarterly for the remaining twenty-four months.